Results

Total Results: 5,399 records

Showing results for "stakeholder".
Users also searched for: quality

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_executive.pdf
    March 01, 2012 - 1 Comparative Effectiveness Review Number 50 Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children Executive Summary Background Musculoskeletal (MSK) pain is common in children and adolescents, with an estimated prevalence rangin…
  2. effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
    January 01, 2018 - has been some critique of their degree of rigor (e.g., use of systematic reviews of the evidence), stakeholder
  3. digital.ahrq.gov/sites/default/files/docs/citation/HealthITHazardManagerFinalReport.pdf
    May 01, 2012 - Hazard Manager is intended to support an industry-wide learning community by addressing the following stakeholder
  4. digital.ahrq.gov/sites/default/files/docs/citation/workflowredesignrfi.pdf
    July 01, 2010 - Stakeholder feedback will be used to address problems, impediments, and inefficiencies as well as to … Stakeholder feedback will be used to address problems, impediments, and inefficiencies, as well as to
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-disposition.pdf
    June 22, 2017 - Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update Draft review available for public com…
  6. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_executive.pdf
    April 01, 2011 - Layout 1 Background Autism spectrum disorders (ASDs) have an estimated prevalence of 1 in 110 children in the United States.1 Disorders within the spectrum include Autistic Disorder, Asperger Syndrome, and Pervasive Developmental Disorder, Not Otherwise Specified (PDD-NOS). Individuals with ASDs have impaired socia…
  7. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
    December 01, 2011 - Layout 1 Background Coronary stents and adjunctive pharmacologic agents—including glycoprotein IIb/IIIa receptor inhibitors and thienopyridines—have improved the efficacy of percutaneous coronary intervention (PCI).1,2 However, dislodgement of atherothrombotic material from coronary lesions during PCI can result in …
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
    March 01, 2013 - 1 Comparative Effectiveness Review Number 61 Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of Preventive Medical Strategies Executive Summary Introduction Nephrolithiasis is a condition in which hard masses (kidney stones) form within the urinary tract. These stones form from crystals that…
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/telehealth_disposition-comments.pdf
    June 30, 2016 - Evidence-based Practice Center Systematic Review Protocol Source: https://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/ ?pageaction=displayproduct&productid=2254 Published Online: June 30, 2016 Technical Brief Disposition of Comments Report Research Review Title: Telehealth: M…
  10. effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
    May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
    May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
    April 01, 2013 - 1 Comparative Effectiveness Review Number 117 Pulmonary Arterial Hypertension: Screening, Management, and Treatment Executive Summary Background Epidemiology and Etiology of Pulmonary Arterial Hypertension Pulmonary arterial hypertension (PAH), a subcategory of pulmonary hypertension (PH), is a rare and pr…
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_executive.pdf
    July 01, 2012 - 1 Comparative Effectiveness Review Number 68 Noninvasive Positive-Pressure Ventilation (NPPV) for Acute Respiratory Failure Executive Summary Background Acute respiratory failure is a life- threatening condition characterized by an inability to maintain normal levels of oxygen and/or carbon dioxide gas exc…
  14. effectivehealthcare.ahrq.gov/sites/default/files/technical-brief-36-patient-engagement-comments.pdf
    August 26, 2020 - Disposition of Comments for Technical Brief 36: Strategies for Patient, Family, and Caregiver Engagement Technical Brief Disposition of Comments Report Title: Strategies for Patient, Family, and Caregiver Engagement Draft report available for public comment from February 04, 2020 to March 06, 2020. …
  15. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0242-fullreport.pdf
    February 01, 2020 - Follow-up Visits for Children Who Are Obese or Overweight with a Weight-Related Comorbidity: Report 1 Follow-up Visits for Children Who Are Obese or Overweight with a Weight-Related Comorbidity Section 1. Basic Measure Information 1.A. Measure Name Follow-up Visits for Children Who Are Obese or Overweight wi…
  16. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-230-fullreport.pdf
    July 01, 2019 - CHIPRA 230: Documentation of BMI Percentile and Weight Classification for Children 1 Documentation of BMI Percentile and Weight Classification for Children Section 1. Basic Measure Information 1.A. Measure Name Documentation of BMI Percentile and Weight Classification for Children 1.B. Measure Number 0230 1…
  17. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-208-fullreport.pdf
    May 13, 2019 - Neonatal Intensive Care All-Condition Readmissions Without Gestational Age: Full Report Neonatal Intensive Care All-Condition Readmissions Without Gestational Age Section 1. Basic Measure Information 1.A. Measure Name Neonatal Intensive Care All-Condition Readmissions Without Gestational Age 1.B. Measure Number…
  18. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-207-fullreport.pdf
    June 01, 2019 - Neonatal Intensive Care All-Condition Readmissions with Gestational Age Reported 1 Neonatal Intensive Care All-Condition Readmissions with Gestational Age Reported Section 1. Basic Measure Information 1.A. Measure Name Neonatal Intensive Care All-Condition Readmissions with Gestational Age Reported 1.B. Measu…
  19. integrationacademy.ahrq.gov/products/topic-briefs/behavioral-health-apps
    July 01, 2024 - An official website of the Department of Health & Human Services Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates The Academy Integrating Behavioral Health & Primary Care Expand Navi…
  20. www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/surgery/43-pathway-worksheet.docx
    June 01, 2023 - Improving Surgical Care and Recovery Core and Surgery Specific Pathways Worksheet Use this worksheet to develop enhanced recovery pathways for use at your hospital. The information in this tool is based on evidence reviews (see appendix) conducted by the National Project Team at the American College of Surgeons and Jo…